DRG Market Assessment 보고서
질환 개요 및 예측, 역학 인텔리전스, 바이오시밀러 인텔리전스, China In-depth 등 폭넓은 시장 인텔리전스를 확인해 보세요.
Biosimilars | Market Events and Forecast Landscape – Forecast Methodology and General Market Assumptions | 2023
In 2021, sales of branded biologics for oncology, immunology, endocrinology, nephrology, respiratory, and ophthalmology indications exceeded $130 billion in the major pharmaceutical markets under…
Biomarkers in Oncology | Access & Reimbursement | US | Non-Small-Cell Lung Cancer, Breast Cancer, and Colorectal Cancer | 2023
Biomarker-driven prescribing is paramount in key oncology indications. The use of biomarkers is entrenched in non-small-cell lung cancer (NSCLC), breast cancer, and colorectal cancer. Biomarker-…
Metabolic Dysfunction-Associated Steatohepatitis – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of NASH comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the total NASH prevalent cases for each country, as…
Metabolic Dysfunction-Associated Steatohepatitis – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key non-alcoholic steatohepatitis patient populations, covering 171…
